Beta Bionics to Announce Third Quarter 2025 Financial Results on October 28, 2025
Rhea-AI Summary
Beta Bionics (Nasdaq: BBNX) will release its third quarter 2025 financial results after market close on Tuesday, October 28, 2025. Management will host a conference call and concurrent webcast the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time). The webcast link will be posted and archived in the company’s Investors & Events section at https://investors.betabionics.com. Phone access requires registration for dial-in details and a personal PIN via https://register-conf.media-server.com/register/BI0b27b735377640268ec22270324ddd73.
Positive
- None.
Negative
- None.
IRVINE, Calif., Oct. 09, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced that it plans to release its third quarter 2025 financial results after the financial markets close on Tuesday, October 28, 2025. Management will host a conference call and concurrent webcast on the same day at 4:30 pm Eastern Time (1:30 pm Pacific Time).
The link to the webcast will be available on the Company’s website in the “Investors—Events & Presentations” section at https://investors.betabionics.com, and will be archived there for future replay. To access the live call by phone, please use the following link, which will provide you with dial-in details and a personal pin: https://register-conf.media-server.com/register/BI0b27b735377640268ec22270324ddd73
About Beta Bionics
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development, and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The iLet Bionic Pancreas is the first FDA-cleared insulin delivery device that autonomously determines every insulin dose and offers the potential to substantially improve overall outcomes across broad populations of PWD. To learn more, visit www.betabionics.com.
Investor Relations:
Blake Beber
Head of Investor Relations
ir@betabionics.com
Media and Public Relations:
Karen Hynes
Vice President of Marketing
media@betabionics.com
Source: Beta Bionics, Inc.
FAQ
When will Beta Bionics (BBNX) release Q3 2025 results?
What time is the Beta Bionics (BBNX) Q3 2025 earnings call and webcast?
Where can I find the Beta Bionics (BBNX) webcast for the October 28, 2025 call?
How do I join Beta Bionics (BBNX) Q3 2025 call by phone?
Will the Beta Bionics (BBNX) webcast be available after the live event?
Is the Beta Bionics (BBNX) Q3 2025 announcement scheduled before or after market hours?
